Wir sind mit live!
Mehr erfahren
Chemomab Therapeutics
| Name | Position | Handelswert |
Veränderung Aktien |
Anteils- änderung |
|
|---|---|---|---|---|---|
1
OrbiMed
New York
| 2,95 Mio. $ | – | – | – |
|
2
Ikarian Capital
Dallas,
Texas
| 279.543 $ | -36.772 $ | -5.829 | -10 % |
|
3
Kestra Private Wealth Services
Austin,
Texas
| 41.082 $ | – | – | – |
|
4
Boothbay Fund Management
New York
| 34.886 $ | – | – | – |
|
5
Geode Capital Management
Boston,
Massachusetts
| 15.375 $ | – | – | – |
|
6
Advisory Services Network
Atlanta,
Georgia
| 14.692 $ | – | – | – |
|
7
RhumbLine Advisers
Boston,
Massachusetts
| 3.936 $ | +4.738 $ | +751 | Neu |
|
8
Osaic Holdings
Scottsdale,
Arizona
| 3.580 $ | – | – | – |
|
9
Newbridge Financial Services Group
Boca Raton,
Florida
| 1.447 $ | – | – | – |
|
10
Morgan Stanley
New York
| 132 $ | -12.144 $ | -1.925 | -99 % |
|
11
UBS Group
Zurich,
Switzerland
| 16 $ | -631 $ | -100 | -97 % |
|
12
Cormorant Asset Management
Boston,
Massachusetts
| – | -458.000 $ | -72.042 | Geschlossen |
|
13
Two Sigma Investments
New York
| – | -48.118 $ | -7.566 | Geschlossen |
|
14
Two Sigma Advisers
New York
| – | -18.762 $ | -2.950 | Geschlossen |
|